Variant report
Variant | esv32725 |
---|---|
Chromosome Location | chr15:55064314-55064638 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:55062888..55065533-chr15:55066470..55069394,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs71458450 | chr15:55064319-55064320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147668026 | chr15:55064324-55064325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552305888 | chr15:55064330-55064331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs76796547 | chr15:55064377-55064378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374866413 | chr15:55064382-55064383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369355249 | chr15:55064396-55064397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372513765 | chr15:55064403-55064404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548315681 | chr15:55064432-55064433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181611288 | chr15:55064438-55064439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536068903 | chr15:55064439-55064440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556292673 | chr15:55064449-55064450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569864254 | chr15:55064450-55064451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538882600 | chr15:55064494-55064495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs377052474 | chr15:55064529-55064530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116015080 | chr15:55064532-55064533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572120598 | chr15:55064540-55064541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541020606 | chr15:55064570-55064571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554741474 | chr15:55064622-55064623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76093756 | chr15:55064627-55064628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186269790 | chr15:55064629-55064630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2651750 | chr15:55064630-55064631 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22032731 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:55062600-55064400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
2 | chr15:55062800-55064400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr15:55062800-55064800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr15:55064400-55065000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr15:55064400-55065600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |